Salarius Pharmaceuticals (SLRX) executive Rosenblum received 7,787 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Mark J Rosenblum (executive at Salarius Pharmaceuticals Inc., SLRX) reported that they received 7,787 shares on Nov 3, 2021. After these transactions the filing shows 34,073 shares held directly.
- Reporting person
- Rosenblum Mark J
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Nov 3, 2021 | Grant or award (A) | Common Stock1 | +7,787 | $0.72 | $5,591 | 34,073 direct |
Holdings before and after
- Common Stock: 26,286 to 34,073 direct
Footnotes from the filing
- 1. The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuant to the issuer's Employee Stock Purchase Plan.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Rosenblum report in this SLRX Form 4?
Mark J Rosenblum (executive at Salarius Pharmaceuticals Inc., SLRX) reported that they received 7,787 shares on Nov 3, 2021. After these transactions the filing shows 34,073 shares held directly.
How many SLRX shares does Rosenblum hold after this filing?
The filing shows 34,073 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for SLRX
Earlier insider filings at SLRX
- Aug 17, 2021SEC Form 4 filed by Salarius Pharmaceuticals, Inc.
- Aug 11, 2021SEC Form 4 filed by Salarius Pharmaceuticals, Inc.
- May 5, 2021SEC Form 4: Rosenblum Mark J was granted 9,563 units of Common Stock, increasing direct ownership by 57% to 26,286 units
- May 5, 2021SEC Form 4: Arthur David J. was granted 9,822 units of Common Stock, increasing direct ownership by 11% to 96,247 units
Quantisnow market dataNASDAQ
SLRX
Salarius Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2015
Get push alerts for SLRX
Full SLRX profile on Quantisnow Follow SLRX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time